meningococcal conjugate vaccines
GPTKB entity
Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:vaccine
|
| gptkbp:administeredBy |
adolescents
adults children |
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA |
| gptkbp:boosterRecommended |
yes
|
| gptkbp:broadcastOn |
2 doses for adolescents
|
| gptkbp:contains |
gptkb:amino_acid_transporter
polysaccharide antigens |
| gptkbp:example |
gptkb:Menveo
gptkb:Nimenrix gptkb:Menactra MenACWY |
| gptkbp:prevention |
meningococcal disease
|
| gptkbp:protectedBy |
serogroup A
serogroup C serogroup W serogroup Y |
| gptkbp:routeOfAdministration |
intramuscular
|
| gptkbp:sideEffect |
fever
headache injection site pain |
| gptkbp:target |
gptkb:Neisseria_meningitidis
|
| gptkbp:WHOModelListOfEssentialMedicines |
yes
|
| gptkbp:bfsParent |
gptkb:CRM197_protein
|
| gptkbp:bfsLayer |
8
|
| http://www.w3.org/2000/01/rdf-schema#label |
meningococcal conjugate vaccines
|